A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants

Exclusion Criteria

• •Allergic to the active ingredient in the vaccine, any inactive ingredient, or substance used in the manufacturing process;
• •Allergic to this product or similar vaccines in the past;
• •Patients with severe chronic diseases or allergies;
• •Patients with fever or acute illness.
• •Any serious adverse events that are causally related to vaccination;
• •Severe anaphylaxis or hypersensitivity after vaccination (including hives and rashes within 30 minutes of vaccination);
• •Any confirmed or suspected autoimmune or immunodeficiency disease, including human immunodeficiency virus (HIV) infection;
• •Acute or newly emerging chronic diseases occur at the time of vaccination;
• •Other reactions (including severe pain, severe swelling, severe limitation of movement, persistent high fever, severe headache, or other systemic or local reactions), as determined by the investigator;
• •Having an acute illness at the time of vaccination (acute illness is defined as moderate or severe illness with or without fever);
• •Axillary temperature \>37℃ during vaccination.